{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:41:08Z","timestamp":1791294068943,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Health and Family Planning Commission of Sichuan Province","award":["17PJ485"],"award-info":[{"award-number":["17PJ485"]}],"id":[{"id":"https:\/\/ror.org\/00kx6j950","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Discipline Talent Promotion Program of \"Xinglin Scholars\u201d","award":["QNXZ2018005"],"award-info":[{"award-number":["QNXZ2018005"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Phytomedicine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.phymed.2018.11.019","type":"journal-article","created":{"date-parts":[[2018,11,19]],"date-time":"2018-11-19T12:05:31Z","timestamp":1542629131000},"page":"152759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways"],"prefix":"10.1016","volume":"59","author":[{"given":"Hai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-chuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6862-634X","authenticated-orcid":false,"given":"Xiao-fei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phymed.2018.11.019_bib0001","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.cld.2015.01.007","article-title":"Surgical resection and liver transplantation for hepatocellular carcinoma","volume":"19","author":"Akoad","year":"2015","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.phymed.2018.11.019_bib0002","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cyto.2017.03.018","article-title":"STAT3 in cancer: A double edged sword","volume":"98","author":"Avalle","year":"2017","journal-title":"Cytokine"},{"key":"10.1016\/j.phymed.2018.11.019_bib0003","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1158\/2159-8290.CD-16-0860","article-title":"Targeting DNA repair in cancer: Beyond PARP inhibitors","volume":"7","author":"Brown","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.phymed.2018.11.019_bib0004","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1080\/02841860902974175","article-title":"Apoptosis in cancer: Key molecular signaling pathways and therapy targets","volume":"48","author":"Burz","year":"2009","journal-title":"Acta Oncol."},{"key":"10.1016\/j.phymed.2018.11.019_bib0005","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrc2696","article-title":"Emerging roles of E2Fs in cancer: an exit from cell cycle control","volume":"9","author":"Chen","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2018.11.019_bib0006","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1039\/b906520m","article-title":"Pseudolaric acids: isolation, bioactivity and synthetic studies","volume":"27","author":"Chiu","year":"2010","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.phymed.2018.11.019_bib0007","doi-asserted-by":"crossref","first-page":"5613","DOI":"10.18632\/oncotarget.6723","article-title":"CD147 regulates cancer migration via direct interaction with Annexin A2 and DOCK3-\u03b2-catenin-WAVE2 signaling","volume":"7","author":"Cui","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2018.11.019_bib0008","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm3722","article-title":"Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy","volume":"15","author":"Czabotar","year":"2014","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"10.1016\/j.phymed.2018.11.019_bib0009","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1517\/14728222.2011.639361","article-title":"The RAS\/RAF\/MEK\/ERK and the PI3K\/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches","volume":"16","author":"De Luca","year":"2012","journal-title":"Expert. Opin. Ther. Targets"},{"key":"10.1016\/j.phymed.2018.11.019_bib0010","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2005.06.009","article-title":"Erk associates with and primes GSK-3\u03b2 for its inactivation resulting in upregulation of \u03b2-catenin","volume":"19","author":"Ding","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.phymed.2018.11.019_bib0011","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/35077213","article-title":"Proliferation, cell cycle and apoptosis in cancer","volume":"411","author":"Evan","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.phymed.2018.11.019_bib0012","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.biochi.2018.06.018","article-title":"A new xanthatin analogue 1\u03b2;-hydroxyl-5\u03b1;-chloro-8-epi-xanthatin induces apoptosis through ROS-mediated ERK\/p38 MAPK activation and JAK2\/STAT3 inhibition in human hepatocellular carcinoma","volume":"152","author":"Fang","year":"2018","journal-title":"Biochimie"},{"key":"10.1016\/j.phymed.2018.11.019_bib0013","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3390\/nu9060621","article-title":"Lipid accumulation in HepG2 cells is attenuated by Strawberry extract through AMPK activation","volume":"9","author":"Forbes-Hern\u00e1ndez","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/j.phymed.2018.11.019_bib0014","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2017.09.016","article-title":"Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine","volume":"68","author":"Fujiwara","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.phymed.2018.11.019_bib0015","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1021\/acschembio.5b00945","article-title":"Strategies and approaches of targeting STAT3 for cancer treatment","volume":"11","author":"Furtek","year":"2016","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.phymed.2018.11.019_bib0016","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1126\/science.1171721","article-title":"Mitochondrial STAT3 supports Ras-dependent oncogenic transformation","volume":"324","author":"Gough","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.phymed.2018.11.019_bib0017","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2018.11.019_bib0018","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/1476-4598-9-236","article-title":"Convergence between Wnt-\u03b2-catenin and EGFR signaling in cancer","volume":"9","author":"Hu","year":"2010","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.phymed.2018.11.019_bib0019","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.dnarep.2016.04.008","article-title":"Multiple functions of p21 in cell cycle, apoptosis and transcriptional regulation after DNA damage","volume":"42","author":"Karimian","year":"2016","journal-title":"DNA Repair"},{"key":"10.1016\/j.phymed.2018.11.019_bib0020","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.critrevonc.2016.06.007","article-title":"Hepatocellular carcinoma: Exploring the impact of ethnicity on molecular biology","volume":"105","author":"Lamarca","year":"2016","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.phymed.2018.11.019_bib0021","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.4161\/cbt.7.11.6837","article-title":"Concomitant activation of the JAK\/STAT3 and ERK1\/2 signaling is involved in leptin-mediated proliferation of renal cell carcinoma Caki-2 cells","volume":"7","author":"Li","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.phymed.2018.11.019_bib0022","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3389\/fphar.2017.00394","article-title":"A systematic review of the immune-regulating and anticancer activities of pseudolaric acid B","volume":"8","author":"Liu","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phymed.2018.11.019_bib0023","doi-asserted-by":"crossref","first-page":"11851","DOI":"10.1158\/0008-5472.CAN-06-1377","article-title":"Sorafenib blocks the RAF\/MEK\/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC\/PRF\/5","volume":"66","author":"Liu","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.phymed.2018.11.019_bib0024","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3109\/07853890.2014.912836","article-title":"PI3K\/AKT signaling pathway and cancer: an updated review","volume":"46","author":"Martini","year":"2014","journal-title":"Ann Med."},{"key":"10.1016\/j.phymed.2018.11.019_bib0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/biof.1324","article-title":"Deoxyelephantopin induces apoptosis in HepG2 cells via oxidative stress, NF\u2010\u03baB inhibition and mitochondrial dysfunction","volume":"43","author":"Mehmood","year":"2017","journal-title":"Biofactors"},{"key":"10.1016\/j.phymed.2018.11.019_bib0026","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1053\/j.gastro.2015.02.056","article-title":"\u03b2-catenin signaling and roles in liver homeostasis, injury, and tumorigenesis","volume":"148","author":"Monga","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.phymed.2018.11.019_bib0027","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.cell.2017.05.016","article-title":"Wnt\/\u03b2-catenin signaling, disease, and emerging therapeutic modalities","volume":"169","author":"Nusse","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.phymed.2018.11.019_bib0028","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/jso.20006","article-title":"Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma","volume":"85","author":"Osada","year":"2004","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.phymed.2018.11.019_bib0029","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-2184.2012.00845.x","article-title":"Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis","volume":"45","author":"Ouyang","year":"2012","journal-title":"Cell Prolif"},{"key":"10.1016\/j.phymed.2018.11.019_bib0030","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1158\/1078-0432.CCR-11-2381","article-title":"The clinical effect of the dual-targeting strategy involving PI3K\/AKT\/mTOR and RAS\/MEK\/ERK pathways in patients with advanced cancer","volume":"18","author":"Shimizu","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2018.11.019_bib0031","article-title":"The inhibitory effect of pseudolaric acid B on gastric cancer and multidrug resistance via Cox-2\/PKC-\u03b1\/P-gp pathway","volume":"9","author":"Sun","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phymed.2018.11.019_bib0032","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1158\/1078-0432.CCR-15-2240","article-title":"Molecular pathways: Revisiting glycogen synthase kinase-3\u03b2 as a target for the treatment of cancer","volume":"23","author":"Walz","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2018.11.019_bib0033","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1097\/CAD.0000000000000500","article-title":"Pseudolaric acid B induces endometrial cancer Ishikawa cell apoptosis and inhibits metastasis through AKT-GSK-3\u03b2 and ERK1\/2 signaling pathways","volume":"28","author":"Wang","year":"2017","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.phymed.2018.11.019_bib0034","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.yexcr.2017.01.012","article-title":"Pseudolaric acid B inhibits gastric cancer cell metastasis in vitro and in haematogenous dissemination model through PI3K\/AKT, ERK1\/2 and mitochondria-mediated apoptosis pathways","volume":"352","author":"Wang","year":"2017","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.phymed.2018.11.019_bib0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.18632\/oncotarget.2801","article-title":"CD147 promotes Src-dependent activation of Rac1 signaling through STAT3\/DOCK8 during the motility of hepatocellular carcinoma cells","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.phymed.2018.11.019_bib0036","first-page":"157","article-title":"Cancer-related issues of CD147","volume":"7","author":"Weidle","year":"2010","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.phymed.2018.11.019_bib0037","doi-asserted-by":"crossref","first-page":"6002","DOI":"10.1158\/1078-0432.CCR-05-0209","article-title":"Pseudolaric acid B, a novel microtubule-destabilizing agent that circumvents multidrug resistance phenotype and exhibits antitumor activity in vivo","volume":"11","author":"Wong","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2018.11.019_bib0038","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1142\/S0192415X06004363","article-title":"Mechanisms of pseudolaric acid B-induced apoptosis in Bel-7402 cell lines","volume":"34","author":"Wu","year":"2006","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.phymed.2018.11.019_bib0039","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1745-7254.2008.00835.x","article-title":"Protein tyrosine kinase, JNK, and ERK involvement in pseudolaric acid B-induced apoptosis of human breast cancer MCF-7 cells","volume":"29","author":"Yu","year":"2008","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phymed.2018.11.019_bib0040","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nrc3818","article-title":"Revisiting STAT3 signalling in cancer: new and unexpected biological functions","volume":"14","author":"Yu","year":"2014","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.phymed.2018.11.019_bib0041","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1158\/1078-0432.CCR-17-0692","article-title":"Degalactotigonin, a natural compound from Solanum nigrum L., inhibits growth and metastasis of osteosarcoma through GSK3\u03b2 inactivation-mediated repression of the Hedgehog\/Gli1 pathway","volume":"24","author":"Zhao","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.phymed.2018.11.019_bib0042","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.1039\/C7CC04345G","article-title":"Chemical proteomics reveal CD147 as a functional target of pseudolaric acid B in human cancer cells","volume":"53","author":"Zhou","year":"2017","journal-title":"Chem. Commun."},{"key":"10.1016\/j.phymed.2018.11.019_bib0043","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/aps.2017.5","article-title":"New knowledge of the mechanisms of sorafenib resistance in liver cancer","volume":"38","author":"Zhu","year":"2017","journal-title":"Acta Pharmacol. Sin."}],"container-title":["Phytomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711318305592?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944711318305592?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T15:58:34Z","timestamp":1790006314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944711318305592"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":43,"alternative-id":["S0944711318305592"],"URL":"https:\/\/doi.org\/10.1016\/j.phymed.2018.11.019","relation":{},"ISSN":["0944-7113"],"issn-type":[{"value":"0944-7113","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pseudolaric acid B exhibits anti-cancer activity on human hepatocellular carcinoma through inhibition of multiple carcinogenic signaling pathways","name":"articletitle","label":"Article Title"},{"value":"Phytomedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phymed.2018.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152759"}}